B. Metzler seel. Sohn & Co. AG Has $6.33 Million Holdings in Cigna Group $CI

B. Metzler seel. Sohn & Co. AG increased its position in shares of Cigna Group (NYSE:CI) by 28.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,959 shares of the health services provider’s stock after buying an additional 4,872 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in Cigna Group were worth $6,330,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of CI. Dynamic Technology Lab Private Ltd bought a new position in shares of Cigna Group in the 3rd quarter worth about $3,341,000. Vinva Investment Management Ltd lifted its stake in shares of Cigna Group by 21.8% in the 3rd quarter. Vinva Investment Management Ltd now owns 22,973 shares of the health services provider’s stock valued at $6,585,000 after purchasing an additional 4,105 shares during the period. Meiji Yasuda Life Insurance Co boosted its position in shares of Cigna Group by 37.3% during the 3rd quarter. Meiji Yasuda Life Insurance Co now owns 1,082 shares of the health services provider’s stock valued at $312,000 after purchasing an additional 294 shares in the last quarter. Korea Investment CORP grew its stake in Cigna Group by 9.7% during the third quarter. Korea Investment CORP now owns 218,840 shares of the health services provider’s stock worth $63,081,000 after purchasing an additional 19,435 shares during the period. Finally, Rhenman & Partners Asset Management AB grew its stake in Cigna Group by 45.3% during the third quarter. Rhenman & Partners Asset Management AB now owns 46,500 shares of the health services provider’s stock worth $13,404,000 after purchasing an additional 14,500 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

CI has been the topic of several recent analyst reports. Robert W. Baird dropped their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. TD Cowen raised their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Guggenheim reiterated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Monday, February 2nd. Finally, Truist Financial increased their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $330.42.

Cigna Group Stock Performance

Shares of CI opened at $271.50 on Monday. The firm has a market capitalization of $71.55 billion, a P/E ratio of 12.24, a P/E/G ratio of 0.94 and a beta of 0.27. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The stock has a 50 day moving average price of $280.71 and a two-hundred day moving average price of $283.97. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the company earned $6.64 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.